Mechanisms and clinical consequences of untreated central sleep apnea in heart failure

Area of Science:

• Cardiology
• Sleep Medicine
• Respiratory Medicine

Background:

• Central sleep apnea (CSA) is a frequent comorbidity in heart failure (HF) patients, affecting 30-50%.
• CSA significantly contributes to HF progression, morbidity, and mortality.
• Understanding CSA's pathophysiologic mechanisms is crucial for developing effective treatments.

Purpose of the Study:

• To review the current understanding of CSA mechanisms in HF.
• To discuss emerging therapies for treating CSA in HF patients.
• To highlight the goal of improving patient quality of life and clinical outcomes.

Main Methods:

• Literature review of pathophysiologic mechanisms of CSA in HF.
• Analysis of current research on CSA treatment strategies.
• Synthesis of findings from sleep, respiratory, and cardiovascular research.

Main Results:

• CSA is a significant factor in HF progression and adverse outcomes.
• Ongoing research is elucidating the complex mechanisms underlying CSA in HF.
• New therapeutic approaches for CSA in HF are emerging.

Conclusions:

• Effective management of CSA is essential for improving HF patient prognosis.
• Further research into CSA mechanisms and treatments holds promise for better patient care.
• Integrated approaches targeting both HF and CSA are needed.